Cached score snapshot

US.ELV · Elevance Health

110分制 58.6/110;5D動能v2 7/50;排序分 65.6/160

Ranking score 65.6/160
Main score 58.6/110
5D momentum v2 7/50
Rank #110
Setup grade F 30.7

Score breakdown

觀望

Medium twelvedata

Score and price trend

F 30.7 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 06-25 08-07 09-21 10-12 10-30 $353.20$424.12$495.03 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.31 · anchors 120 +1.34% -1.41% / +3.09% 63.8% 3.8% Actual outcome pending · 0 / 3 bars observed
30D observation +8.83% +1.26% / +13.56% 78.8% 10% Actual outcome pending · 0 / 30 bars observed
Historical projection 10D n=160 +0.56% -1.60% / +2.70% 56.9% 4.4% Actual outcome pending · 0 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-06-25 → 2026-10-30 · 120 archived points · 1 Improving turn signal · 7 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 65.6
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 58.6/110 (觀望)
5D momentum v2 7/50 (弱)
Score with momentum v2 65.6/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 406.7735
ma50 397.2122
close 410.95
prevClose 414.26
avgVolume20 1123860
volumeRatio 1.85
changePercent -0.8

Metrics snapshot

close 410.95
volume 2074605
changePercent -0.8

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 58.6/110
Main rating 觀望
5D momentum v2 7/50
Score with momentum v2 65.6/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.8/5 · 良好

Dimension score 3.8/5
Dimension grade 良好

Sub-items

pbPoints 0.5
pePoints 0.5
epsPoints 0
roePoints 0.4
debtPoints 0.5
marginPoints 0
turnoverUsdM 852.5589
volumePoints 0.5
revenuePoints 0.6
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 9.2/20 · 較差

Dimension score 9.2/20
Dimension grade 較差

Sub-items

cmfPoints 0.8
mfiPoints 1.6
obvPoints 0.8
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.ELV
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 11.2/15 · 良好

Dimension score 11.2/15
Dimension grade 良好

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 15.44

trend

score 3.4

details

qqq

ma20 713.2355
ma50 709.9512
name QQQ
close 721.45
points 2

spy

ma20 764.3035
ma50 759.731
name SPY
close 761.69
points 1.4
source twelvedata+fred
atrPct 2.6418
atrPoints 3
cciPoints 2.4
vixPoints 2.4
marketTrendPoints 3.4

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 0
catalystPoints 2

風險管理 — 7/10 · 良好

Dimension score 7/10
Dimension grade 良好

Sub-items

position

score 1.6

details

atrPct 2.6418
turnoverUsdM 852.5589
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.6

stopLevels

symbol US.ELV
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 389.2372

strength_details

ma_score 1.5
atr_score 2
rsi_score 2
macd_score 3
volume_score 2
market_adjustment 1
risk_reward_ratio 1.6
stop_loss_percent 5.3
take_profit_price 445.1839
target_multiplier 2.2
technical_strength 2.15
take_profit_percent 8.3
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.5709
stopLossPercent 5.2836
diversificationPoints 2

技術信號 — 19.4/30 · 一般

Dimension score 19.4/30
Dimension grade 一般

Sub-items

bbPoints 3
adxPoints 3
sarPoints 2.4
vcpPoints 0.9
macdPoints 4

vcpPayload

vcp_pass false
vcp_score 0.9
vcp_reason 站上MA50;升放量(近10日4日);Ready=N;Confirm=N

vcp_metrics

up_days 4
vol_ref 999150
down_days 5
vcp_ready false
above_ma50 true
avg_vol_10 1290450
avg_vol_20 1060775
avg_vol_30 999150
range_pct_10 0.087
range_pct_20 0.0885
range_pct_30 0.1006
up_expand_ok true
lookback_used 59
near_20d_high true
contraction_ok false
down_shrink_ok false
up_expand_days 4
breakout_20d_ok false
vol_ratio_10_30 1.2915
dist_to_20d_high 0.038
down_shrink_days 0
breakout_level_20d 427.17
vcp_breakout_confirm false
contraction_ratio_10_30 0.8655
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction false
kdjAdxPoints 0.5
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0
shortMacdPoints 0.4
volConfirmPoints 0
volumePointsTechnical 1.2

情緒分析 — 6/10 · 一般

Dimension score 6/10
Dimension grade 一般

Sub-items

sentiment

score 6

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 4
sentimentScoreRaw 1.2

sentimentData

raw {"id":142195356,"url":"https://finnhub.io/api/news?id=5026d066d14e93fd285f14b67eee910d578590ab1da321b577e3d0ffffe17858","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.","category":"company","datetime":1789566004,"headline":"Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?"}, {"id":142165895,"url":"https://finnhub.io/api/news?id=4e306319d28b9c86fab6c2c9dd4c4556d7f2825f07cdf375061043fa75828a64","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"ELV vs. DHR: Which Stock Is the Better Value Option?","category":"company","datetime":1789486803,"headline":"ELV or DHR: Which Is the Better Value Stock Right Now?"}, {"id":141950829,"url":"https://finnhub.io/api/news?id=0d6a03820241bbbe5b1f009058d13066016bbfb4577f67b0d52a1150f1e424ee","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"What a time it’s been for Elevance Health. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $414.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.","category":"company","datetime":1788876918,"headline":"2 Reasons to Watch ELV and 1 to Stay Cautious"}, {"id":141446869,"url":"https://finnhub.io/api/news?id=f83be2ff10be414db328b84762aa96c3abb7549d3caafc3d998c02964c8ed095","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"After a strong 37.5% return over the past year, Elevance Health now trades with a high value score and an undervalued read on market multiples, which raises the question of whether the recent share price strength has fully reflected that signal or not. Elevance Health has delivered a 37.5% 1 year return, so any further upside now depends on how much fundamental value is still not priced in. The appointment of Dr. Patrick Fox to lead Carelon Behavioral Services, alongside greater use of AI in...","category":"company","datetime":1788541717,"headline":"Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run"}, {"id":141362847,"url":"https://finnhub.io/api/news?id=46baef09383f41e21789fc2b3f9168ff7c68bd6636fa6ff9171ecead1c90b74f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"First Eagle Investment Management, an investment management company, released its Q2 2026 investor update for “First Eagle Global Fund”. The letter can be downloaded here. Easing tensions in the Middle East led to a strong rally in risk markets in Q2. The S&P 500 Index rose 15.2%, while the MSCI EAFE Index gained 10.8%. Growth […]","category":"company","datetime":1788275973,"headline":"Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability"}, {"id":141362854,"url":"https://finnhub.io/api/news?id=04bd634a8b988a7cf311da2f49c8a860042d2747c93fb4b91b297dd3b8756cb9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Hotchkis & Wiley, an investment management company, released its second-quarter 2026 investor letter for the “Large Cap Fundamental Value Fund.” A copy can be downloaded here. Equity markets posted strong returns, with the Russell 1000 Value Index rising by 13.9%, although many individual stocks lagged. Notably, semiconductor stocks and AI-related sectors saw exceptional gains. The rally […]","category":"company","datetime":1788275589,"headline":"Elevance Health (ELV): Bridging the Gap between Care and Coverage"}, {"id":141348697,"url":"https://finnhub.io/api/news?id=c3f11e3694dec0eb71a42656056e64871a363c44dc7c14ca74f28033388e390f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with Elevance Health (NYSE:ELV).","category":"company","datetime":1787941732,"headline":"Health Insurance Providers Stocks Q2 In Review: Elevance Health (NYSE:ELV) Vs Peers"}, {"id":141348701,"url":"https://finnhub.io/api/news?id=ba59e6db11547a74cca1b53900d2a5fa3b6d53f4b318ab658e604a859899faf5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"In recent weeks, Elevance Health has been highlighted for strong Q2 2026 results, raised full-year guidance, and operational gains driven by AI-enabled efficiency and cost savings. At the same time, the appointment of Dr. Patrick Fox to lead Carelon Behavioral Services underscores Elevance Health’s emphasis on behavioral health capabilities within its broader health services platform. Next, we’ll examine how Elevance’s AI-driven margin improvements and refreshed behavioral health leadership...","category":"company","datetime":1787757179,"headline":"Did AI-Driven Margins and New Behavioral Health Leadership Just Shift Elevance Health's (ELV) Investment Narrative?"}
raw_source {"id":142261918,"url":"https://finnhub.io/api/news?id=46fedd06c559ba8b3d63e97060c25dad3687b4ac45e0e46d0a2425c82202bb5e","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"ELV","summary":"Track weekly dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend dates and pay dates here.","category":"company","datetime":1789755255,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week September 20"}, {"id":142253967,"url":"https://finnhub.io/api/news?id=cc96e85bcbd3f911ee04bc5faedce46fa69ce08f2304cc6523cc0ba700260543","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"CVS Health (CVS) keeps a little over a penny of profit from every dollar it takes in. A net margin of 1.2% reads like a verdict on the business. On $415.1 billion of revenue, one point of net margin is worth over $4 billion, and 1.2% is closer to a floor than a peak. Management has been working on it through 2026.","category":"company","datetime":1789733701,"headline":"Should You Buy CVS Stock For The Margin Aetna Is Rebuilding?"}, {"id":142243261,"url":"https://finnhub.io/api/news?id=97da61e50488ab738935ec0c987e2d2f0bf7f71c8c70942a1e69ff508905292d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.","category":"company","datetime":1789715600,"headline":"2 Surging Stocks on Our Watchlist and 1 We Brush Off"}, {"id":142198233,"url":"https://finnhub.io/api/news?id=62893c934108390cb4e84f708579862ec5e7b3b4291db08db0f2465e4946203f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.","category":"company","datetime":1789579013,"headline":"The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet"}, {"id":142195356,"url":"https://finnhub.io/api/news?id=5026d066d14e93fd285f14b67eee910d578590ab1da321b577e3d0ffffe17858","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.","category":"company","datetime":1789566004,"headline":"Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?"}, {"id":142194544,"url":"https://finnhub.io/api/news?id=fce05d1042311f51521afde0637491e147e66c86aae7741630cbd8ba237fa8a2","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2260474979/image_2260474979.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"ELV","summary":"During the quarter, we added 8 new positions and exited 6 positions, bringing the number of positions in the Fund to 43.","category":"company","datetime":1789548840,"headline":"Baron Health Care Fund Q2 2026 Portfolio Activity"}, {"id":142165895,"url":"https://finnhub.io/api/news?id=4e306319d28b9c86fab6c2c9dd4c4556d7f2825f07cdf375061043fa75828a64","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"ELV vs. DHR: Which Stock Is the Better Value Option?","category":"company","datetime":1789486803,"headline":"ELV or DHR: Which Is the Better Value Stock Right Now?"}, {"id":142165607,"url":"https://finnhub.io/api/news?id=81c3d116e6c3b7c554af98f977c4bc6cd338554110e0abca84fed3a196ba0a12","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"CVS Health's Health Services arm is gaining from pharmacy strength and improving care delivery, with robust new sales and clinic economics supporting growth.","category":"company","datetime":1789481700,"headline":"Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth"}, {"id":142141425,"url":"https://finnhub.io/api/news?id=1319d644a68d1a16e7a0fdb153103e0f98cb9c4ea9eee6a94f946c434dcaf49d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"The health care giant showered its owners with cash, yet the stock spent years in the slow lane. Here’s the accounting of what that trade-off actually delivered.","category":"company","datetime":1789420257,"headline":"CVS Stock Returned $24B In Cash: Why Did It Still Lag The Market?"}, {"id":142141467,"url":"https://finnhub.io/api/news?id=40c7ec190f17456e6d4cedac5eaa7a53021f0b8cfbc64b185ac0b994c06ac9e3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UnitedHealth (UNH) has spent the past year repairing margins rather than chasing growth. The shares rebounded well ahead of any actual margin recovery: up about 38% over the past six months, though down about 6% over the past three, and still behind the S&P 500 over the past twelve months, 12.2% for the stock against 18.6% for the index. What argues for owning them now shows up in cash running ahead of reported profit.","category":"company","datetime":1789414884,"headline":"Should You Buy UNH Stock Because Its Cash Runs Ahead Of Its Profit?"}, {"id":142095118,"url":"https://finnhub.io/api/news?id=741d6ea90e0aa04dbe0d39d21eb4f839bf1c5579d7b3969b84086379cdb5c707","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.","category":"company","datetime":1789177145,"headline":"3 Profitable Stocks to Keep an Eye On"}, {"id":142088283,"url":"https://finnhub.io/api/news?id=8005a02c755811a9a0a209f2f5677afb24b48c9bf148a5123db5ea187fd45728","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"CNC is set to reshape its Medicare Advantage business around dual-eligible members and a simpler footprint to drive margin recovery.","category":"company","datetime":1789143420,"headline":"Can Centene's Medicare Advantage Strategy Unlock Better Margins?"}, {"id":142141590,"url":"https://finnhub.io/api/news?id=6f50b5fe50de9fb6fcc234af99e7fa929b8bff2e5a1b149a55e571d323dcebee","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Key Takeaways:Guidance Raised: Elevance Health lifted 2026 adjusted EPS guidance to at least $27, up from prior levels, after a strong Q2. Price Projection: Based on current execution, ELV stock could reach $494 by December 2028.","category":"company","datetime":1789133912,"headline":"Up 36% in the Last 12 Months, Does Elevance Health Stock Have More Room to Run Through 2028?"}, {"id":142064801,"url":"https://finnhub.io/api/news?id=986a6117d59e8175d3255bd7bd52028ee01dd339371ca80d62205c5bea18363a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.","category":"company","datetime":1789069012,"headline":"Should You Buy Elevance Health Stock For The Margin It Lost?"}, {"id":142064393,"url":"https://finnhub.io/api/news?id=7c28e78d9040a5cce97fe2b77384836940d53d535f5f71724541cccc657ad8ee","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"ELV","summary":"Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.","category":"company","datetime":1789067101,"headline":"Thursday's session: top gainers and losers in the S&P500 index"}, {"id":142063328,"url":"https://finnhub.io/api/news?id=0ddaecaced7b45415c54683e8f459cfc0dd0f482dcb3ec10e83497f59326cbf3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.","category":"company","datetime":1789061100,"headline":"UnitedHealth Reshapes Florida WellMed Operations With TPG Deal"}, {"id":142062620,"url":"https://finnhub.io/api/news?id=42d1713943407a8373594164c6027ae51524d6e82d99ced0e1abd43763cbc25b","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"ELV","summary":"Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.","category":"company","datetime":1789058101,"headline":"What's going on in today's session: S&P500 movers"}, {"id":142064037,"url":"https://finnhub.io/api/news?id=57d493ab3351dc74de676b0cd87b6e9bd1621b6634e7636031016eeb9aed01a9","image":"https://cdn.benzinga.com/files/images/story/2026/09/10/Market--Down--Creative-Crash-Recession-C.jpg?width=2048&height=1536","source":"Benzinga","related":"ELV","summary":"Crude jumped 6% and 30-year Treasury yields hit levels last seen in 2007 as a hot PPI print pushed Fed rate-hike odds toward 70% ahead of Friday's CPI.","category":"company","datetime":1789050419,"headline":"Stock Market Today: Nasdaq 100 Tumbles as Oil Spikes 6%, Yields Hit 19-Year High"}, {"id":142066812,"url":"https://finnhub.io/api/news?id=c3a8490e26f351d1f1e73fe0cfa27c4a9c9d2378d030b2065497eda26ab93539","image":"https://cdn.benzinga.com/files/images/story/2026/09/10/Elevance-Health-Photo-by-Jonathan-Weiss-.jpg?width=2048&height=1536","source":"Benzinga","related":"ELV","summary":"Elevance Health shares are jumping Thursday after the company reaffirmed its FY26 earnings guidance ahead of a series of investor meetings.","category":"company","datetime":1789049583,"headline":"Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation"}, {"id":142060147,"url":"https://finnhub.io/api/news?id=10663dfaeed0ebff97aaefb390f63748c5ff769ad0026a71593c7860874b7688","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Elevance Health Inc (NYSE:ELV) recently announced a total dividend of $1.72 per share, with the ex-dividend date set for 2026-09-10. For investors, the ex-dividend date is a critical marker: shareholders must own the stock before this date to qualify for the upcoming payment. As investors look forward to this next distribution, the spotlight also shines on the company's dividend history, yield, and growth rates.","category":"company","datetime":1789038250,"headline":"Elevance Health Inc's Dividend Analysis"}, {"id":142066813,"url":"https://finnhub.io/api/news?id=75266bf8779312c3481306c942803f68b1d5d054daa55df5708350b7f3aa6de4","image":"","source":"Benzinga","related":"ELV","summary":"Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $20.10 vs $20.26 Est..","category":"company","datetime":1789021705,"headline":"Elevance Health Affirms FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est"}, {"id":142066814,"url":"https://finnhub.io/api/news?id=c83bfcfa124b06b727e41e969f3edbdbe6c30d149d6bbfaf7d6627840dccba4e","image":"","source":"Benzinga","related":"ELV","summary":"Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $27.00 vs $26.91 Est..","category":"company","datetime":1789021680,"headline":"Elevance Health Affirms FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est"}, {"id":142028659,"url":"https://finnhub.io/api/news?id=0081c272b61c689e1879a429e5f7c5cd199146ca47c277f5122abab9309cdee1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.","category":"company","datetime":1788982210,"headline":"Why Is UNH Stock Trading At A Premium With The Slowest Growth?"}, {"id":142025949,"url":"https://finnhub.io/api/news?id=1e60277542dd68ec98f2ca5040753093f4e61bd880edcdf64de9408c92768f2e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.","category":"company","datetime":1788964814,"headline":"UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation"}, {"id":141950829,"url":"https://finnhub.io/api/news?id=0d6a03820241bbbe5b1f009058d13066016bbfb4577f67b0d52a1150f1e424ee","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"What a time it’s been for Elevance Health. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $414.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.","category":"company","datetime":1788876918,"headline":"2 Reasons to Watch ELV and 1 to Stay Cautious"}, {"id":141546908,"url":"https://finnhub.io/api/news?id=8e571c6258a78e295e3d3b62ceae232f24f7212af2894b0de642b2676a6a05ba","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.","category":"company","datetime":1788642735,"headline":"Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2."}, {"id":141485601,"url":"https://finnhub.io/api/news?id=a14fa2d71c991d1424c650e89ccc0365f647e29aec84a754bdf9a4133b2e0743","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"ELV","summary":"Explore this week’s dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend and pay dates.","category":"company","datetime":1788562641,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week September 6"}, {"id":141446869,"url":"https://finnhub.io/api/news?id=f83be2ff10be414db328b84762aa96c3abb7549d3caafc3d998c02964c8ed095","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"After a strong 37.5% return over the past year, Elevance Health now trades with a high value score and an undervalued read on market multiples, which raises the question of whether the recent share price strength has fully reflected that signal or not. Elevance Health has delivered a 37.5% 1 year return, so any further upside now depends on how much fundamental value is still not priced in. The appointment of Dr. Patrick Fox to lead Carelon Behavioral Services, alongside greater use of AI in...","category":"company","datetime":1788541717,"headline":"Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run"}, {"id":141446662,"url":"https://finnhub.io/api/news?id=5d83f5780b6dfb902bdb5621ef012795ad52a453dd0b77ba71da028ec44295d8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.","category":"company","datetime":1788537840,"headline":"UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?"}, {"id":141406653,"url":"https://finnhub.io/api/news?id=0fc4ece3606f4bc356908fcf90fe606852128b69087dfef8e68812e6877e4525","image":"","source":"SeekingAlpha","related":"ELV","summary":"","category":"company","datetime":1788468965,"headline":"Tracking Leon Cooperman's Omega Advisors Portfolio - Q2 2026 Update"}, {"id":141402794,"url":"https://finnhub.io/api/news?id=c5b2226aff37f7fdea42ffc0a3e08c7d47d198279f6393e69e1234a596a2456a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.","category":"company","datetime":1788456945,"headline":"UnitedHealth Stock Recovered Before Its Margins Did"}, {"id":141400357,"url":"https://finnhub.io/api/news?id=19b31dad684a09c10510e4d143d2601be86618c98904802e5c585553b6fe199e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"The market has crowned this healthcare giant the winner of its group, but a look at the underlying business raises the question of whether the celebration started too soon.","category":"company","datetime":1788446735,"headline":"CVS Stock Has Left Its Peers Behind. Or Has It?"}, {"id":141376481,"url":"https://finnhub.io/api/news?id=c5142c9c5bbbb3009728f0775ed74e8ff2bb7da9ccaf6344e74f6c3910f5200e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"CNC's 117% rally now has support from improving margins, firmer pricing and higher earnings expectations, while valuation remains below key peers.","category":"company","datetime":1788360360,"headline":"Centene Stock Roars Back 117% in a Year: Is CNC Still a Buy?"}, {"id":141379955,"url":"https://finnhub.io/api/news?id=9ee49755478826af4de84decd2b0c6ea28d749fc2ddb35d8a026a818d34b6a7c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Elevance Health has underperformed its industry peers over the past year, but analysts are moderately optimistic about the stock’s prospects.","category":"company","datetime":1788353840,"headline":"How Is Elevance Health’s Stock Performance Compared to Other Health Providers?"}, {"id":141369881,"url":"https://finnhub.io/api/news?id=e4986c7e355043e59c656a1c52dbe0d2e2b30ebbe6e03009de611177fa730fe7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"CNC's Marketplace recovery is boosting profitability as better pricing, medical cost trends and risk dynamics reshape its earnings outlook.","category":"company","datetime":1788281640,"headline":"Can Centene's Marketplace Recovery Fuel Stronger Earnings Growth?"}, {"id":141368964,"url":"https://finnhub.io/api/news?id=e5186e485dc68957760302a6c425447b90b006aca680e1528a0a389ed7c70459","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"ELV","summary":"Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.","category":"company","datetime":1788280501,"headline":"Which S&P500 stocks are moving on Tuesday?"}, {"id":141362847,"url":"https://finnhub.io/api/news?id=46baef09383f41e21789fc2b3f9168ff7c68bd6636fa6ff9171ecead1c90b74f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"First Eagle Investment Management, an investment management company, released its Q2 2026 investor update for “First Eagle Global Fund”. The letter can be downloaded here. Easing tensions in the Middle East led to a strong rally in risk markets in Q2. The S&P 500 Index rose 15.2%, while the MSCI EAFE Index gained 10.8%. Growth […]","category":"company","datetime":1788275973,"headline":"Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability"}, {"id":141362854,"url":"https://finnhub.io/api/news?id=04bd634a8b988a7cf311da2f49c8a860042d2747c93fb4b91b297dd3b8756cb9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Hotchkis & Wiley, an investment management company, released its second-quarter 2026 investor letter for the “Large Cap Fundamental Value Fund.” A copy can be downloaded here. Equity markets posted strong returns, with the Russell 1000 Value Index rising by 13.9%, although many individual stocks lagged. Notably, semiconductor stocks and AI-related sectors saw exceptional gains. The rally […]","category":"company","datetime":1788275589,"headline":"Elevance Health (ELV): Bridging the Gap between Care and Coverage"}, {"id":141370499,"url":"https://finnhub.io/api/news?id=449bfd73faa2a0619ff0244e90ac9f9188892e5b55be042037046fe31ded0beb","image":"","source":"Benzinga","related":"ELV","summary":"https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss","category":"company","datetime":1788271464,"headline":"FDA Says It Has Received 990 Adverse Event Reports Tied To Compounded Semaglutide And More Than 730 Tied To Compounded Tirzepatide; Establishes Import Alert For Compounded GLP-1 Active Pharmaceutical Ingredients"}, {"id":141369187,"url":"https://finnhub.io/api/news?id=efc3da274f0ad5bd69acce8293e14118c2980c701e25a977ad4af86808ec1c51","image":"https://cdn.benzinga.com/files/images/story/2026/09/01/New-York-Ny-Usa-march-21--2024-The-New-Y.jpg?width=2048&height=1536","source":"Benzinga","related":"ELV","summary":"The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.","category":"company","datetime":1788267096,"headline":"Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today"}, {"id":141033408,"url":"https://finnhub.io/api/news?id=8ac2e8d39f09e3624d224617145a6038b10b9d9614d10aeb8b095fe16b9b65b8","image":"","source":"Benzinga","related":"ELV","summary":"","category":"company","datetime":1788263573,"headline":"Freenome shares are trading higher after the company announced FDA approval for its SimpleSreen CRC blood-based screening test."}, {"id":141361168,"url":"https://finnhub.io/api/news?id=1cbf7f516ca93aacdc4e94985c792cd793c6948f29279ace82eac658358e283e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Consensus knocks a quarter off the health insurer's earnings multiple over two years, part of it measurement, and almost none of it from selling more coverage.","category":"company","datetime":1788204328,"headline":"UNH Stock Gets Cheaper Only If The Margins Come Back"}, {"id":141348696,"url":"https://finnhub.io/api/news?id=e21e41f3ee9a082fe4b89d56b633a2d96bf0fff4264582b1399beef45b1bd20e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Its market-shock drawdowns have been ordinary in depth, and some of its longest waits back to the old high came after falls the index barely noticed.","category":"company","datetime":1787943961,"headline":"Is CVS Stock Set for a Rebound?"}, {"id":141348697,"url":"https://finnhub.io/api/news?id=c3f11e3694dec0eb71a42656056e64871a363c44dc7c14ca74f28033388e390f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with Elevance Health (NYSE:ELV).","category":"company","datetime":1787941732,"headline":"Health Insurance Providers Stocks Q2 In Review: Elevance Health (NYSE:ELV) Vs Peers"}, {"id":141348698,"url":"https://finnhub.io/api/news?id=9cb7ab406e99ebb67666f4debc44ace31c983016f37660383b80409497e50f1b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1787934624,"headline":"Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?"}, {"id":141348699,"url":"https://finnhub.io/api/news?id=7b9aaf0f06e7f13118a9e7ec9ec53b07edb5eb36492e127cd742bf487132234d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"The healthcare giant sent a fortune back to its owners, but the market yawned. Here’s the real accounting of what that cash bought, and what it didn't.","category":"company","datetime":1787876791,"headline":"Can a $68 Billion Payout Save UNH Stock?"}, {"id":141348700,"url":"https://finnhub.io/api/news?id=ab70e49cb3984bc11c8bfbdab7821b88357b14a0daba3b15666b8acbeca953a3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"CI's Smart Coverage links medical and supplemental benefits, offering up to $7,000 and automated claims for costly health events.","category":"company","datetime":1787844000,"headline":"Can Cigna's Smart Coverage Help Close Health-Cost Gaps?"}, {"id":141326656,"url":"https://finnhub.io/api/news?id=f0ee289a15577c07a4f88b461b3b9df0cab874642345723232053d6898832f08","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1972341389/image_1972341389.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"ELV","summary":"Ruane, Cunniff & Goldfarb Q2 2026 13F: key holdings, new buys & trims, and Sequoia Fund vs S&P 500. Read here for a detailed investment analysis.","category":"company","datetime":1787781184,"headline":"Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2026 Update"}, {"id":141348701,"url":"https://finnhub.io/api/news?id=ba59e6db11547a74cca1b53900d2a5fa3b6d53f4b318ab658e604a859899faf5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"In recent weeks, Elevance Health has been highlighted for strong Q2 2026 results, raised full-year guidance, and operational gains driven by AI-enabled efficiency and cost savings. At the same time, the appointment of Dr. Patrick Fox to lead Carelon Behavioral Services underscores Elevance Health’s emphasis on behavioral health capabilities within its broader health services platform. Next, we’ll examine how Elevance’s AI-driven margin improvements and refreshed behavioral health leadership...","category":"company","datetime":1787757179,"headline":"Did AI-Driven Margins and New Behavioral Health Leadership Just Shift Elevance Health's (ELV) Investment Narrative?"}, {"id":141348702,"url":"https://finnhub.io/api/news?id=2a90f9ffa47c2a658bb35ed845fdefe5b254645d20974fbff3f7fa488adff391","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Elevance Health (ELV) drew fresh attention this week after its Carelon Behavioral Health unit appointed forensic psychiatrist Dr. Patrick Fox as leader, putting behavioral services for more than 61 million members under new oversight. Those leadership changes come as Elevance Health trades at US$398.87, with a 30 day share price return of 5.61% and year to date share price return of 12.60%. The 1 year total shareholder return of 31.36% contrasts with a 3 year total shareholder return that is...","category":"company","datetime":1787745974,"headline":"Elevance Health (ELV) Could Be 11% Undervalued As Carelon Names New Behavioral Health Leader"}, {"id":141348703,"url":"https://finnhub.io/api/news?id=249326dbb0ac108ed2dcd6a2970fc004980a25cf7513cfae72f642c8527d55f3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Sound Shore Management, an investment management firm, has released its investor letter for the second quarter of 2026. The letter can be downloaded here. The Sound Shore Fund’s Investor Class (SSHFX) and Institutional Class (SSHVX) rose 10.48% and 10.58% in the second quarter of 2026, trailing the Russell 1000 Value Index’s 13.87% and the S&P […]","category":"company","datetime":1787685630,"headline":"Is Elevance Health (ELV) a Mispriced Opportunity?"}, {"id":141348704,"url":"https://finnhub.io/api/news?id=f579d4e655a1c6b3865758f2eb885d4aaf89fa1832205ed74d9d2c3be5f56e5d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.","category":"company","datetime":1787677080,"headline":"UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?"}, {"id":141348705,"url":"https://finnhub.io/api/news?id=a697839727b60d968b56f21ed5428c6d3e917c24657401be3326394a8688a31f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Dr. Patrick Fox, a forensic psychiatrist and health plan leader, will take the reins at Carelon Behavioral Services effective immediately. His experience will be “invaluable” for the unit, a top Elevance executive said.","category":"company","datetime":1787653665,"headline":"Elevance’s behavioral health division nabs new president"}, {"id":141348706,"url":"https://finnhub.io/api/news?id=151b0d4bdd9467e584b2144af927c6645c3f8a4360ead424569dce82f9058d54","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Medicare's improvement is real but not a turn in cost trend, while commercial costs keep running higher and the margin fix there has slipped again.","category":"company","datetime":1787594668,"headline":"UnitedHealth Stock's Biggest Risk Sits In The Commercial Book"}, {"id":141348707,"url":"https://finnhub.io/api/news?id=7f5f74d99e12d15db763c6c22ab7d23ac40d8468ba28801a0634d10239c11e38","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Despite Elevance Health's outperformance relative to the broader market over the past 52 weeks, Wall Street analysts remain cautiously optimistic about the stock's prospects.","category":"company","datetime":1787588640,"headline":"Elevance Health Stock Outlook: Is Wall Street Bullish or Bearish?"}, {"id":141278437,"url":"https://finnhub.io/api/news?id=b295eac02aec9c6a14a41b24daf8c516e0e5d52cc2f5cdffb36783e0ac4015ed","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"The healthcare giant is wrestling with costs in one part of its business, and the stock's recent dip has investors wondering if this is the moment to step in.","category":"company","datetime":1787349486,"headline":"Is The Pullback In UNH Stock A Glitch Or A Warning?"}, {"id":141278439,"url":"https://finnhub.io/api/news?id=0aa4c6eab65e8fa1fe312f6d5ad967c837c98714d3987241138d505991dec443","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UNH is prioritizing Medicare Advantage profitability over membership growth, using tighter benefits, pricing and cost controls to improve margins.","category":"company","datetime":1787333520,"headline":"Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?"}, {"id":141280264,"url":"https://finnhub.io/api/news?id=b6a7575647dc6c1fed55742c2871f075dcf6c8397314691554b3e8c20f9bd644","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Medpace (MEDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1787329807,"headline":"Why Is Medpace (MEDP) Up 1.1% Since Last Earnings Report?"}, {"id":141280265,"url":"https://finnhub.io/api/news?id=351df5c90b8bb6fd905405664cbbd083be75975fdd08673ee992605c35a59174","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.","category":"company","datetime":1787327027,"headline":"2 Large-Cap Stocks with Promising Prospects and 1 Facing Headwinds"}, {"id":141278449,"url":"https://finnhub.io/api/news?id=984f68cae88b01dc0468fddba0bc7fb289ae283fd6a8aabceb2bf6c887b1fa62","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"HUM's Star Ratings recovery is set to show early progress, but October's CMS release will test its MA turnaround and path to a 2028 margin target.","category":"company","datetime":1787244420,"headline":"Can Humana's Star Ratings Rebound Unlock MA Earnings Power?"}, {"id":141258963,"url":"https://finnhub.io/api/news?id=a415fc07907197a7f9360b6450ff2edea764c2626a17877f0e266de5b3e9d0aa","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UNH's improving medical costs, higher EPS estimates and capital returns support its recovery, but regulatory risks remain.","category":"company","datetime":1787159760,"headline":"UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now?"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 4
recomputed_at_score true
sentiment_score_raw 1.2
source_article_count 61
discarded_article_count 51
sentimentPoints 6

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.8 5/110 76% 3.8
資金流 9.2 20/110 46% 9.2
市場環境 11.2 15/110 74.67% 11.2
催化劑 2 20/110 10% 2
風險管理 7 10/110 70% 7
技術信號 19.4 30/110 64.67% 19.4
情緒分析 6 10/110 60% 6

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 7/50
ret_5d -0.0186
max_score 50
max_total 50
raw_total 7
vcp_bonus 0
vol_ratio 1.9557
ret_points 0
vol_points 6
range_ratio 0.8903
volat_points 0
day_range_pct 0.0202
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 1
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.6418
turnoverUsdM 852.5589
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.6

stopLevels

symbol US.ELV
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 389.2372

strength_details

ma_score 1.5
atr_score 2
rsi_score 2
macd_score 3
volume_score 2
market_adjustment 1
risk_reward_ratio 1.6
stop_loss_percent 5.3
take_profit_price 445.1839
target_multiplier 2.2
technical_strength 2.15
take_profit_percent 8.3
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.5709
stopLossPercent 5.2836
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.8/5分
資金流分析總分: 9.2/20分
市場環境分析總分: 11.2/15分
催化劑分析: 2/20分
風險管理總分: 7/10分
技術信號分析總分: 19.4/30分
情緒分析: 6/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 85.71
atr
atr 10.8564
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.64
cci
rule Cursor_18.24 CCI bands
level 平衡
score 6
value 31.22
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.1267
kdj
d 66.19
j 56.81
k 63.06
rule Cursor_18.24 K/D cross
score 0
signal 死叉
mfi
rule Cursor_18.24 MFI bands
level 弱流入
score 4
value 42.63
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 2
trend 資金流出
value 5941395
recentSlope -148020.5
previousSlope 51050
rsi
value 59.6
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 404.7761
position SAR喺價下
distancePct 1.5
previousTrend 上升
ma50
value 397.2122
macd
macd 5.2994
trend 強烈看漲
signal 4.9642
histogram 0.3351
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 408.6706
position 連續5日>VWAP
consecutiveAbove 7
volume
rule Cursor_18.24 volume ratio
level 有量
ratio 1.85
score 6
avgVolume 1123860
currentVolume 2074605
derived
ma20 406.7735
ma50 397.2122
prevClose 414.26
avgVolume10 1375331
avgVolume20 1123860
changePercent -0.8
avgVolumeForScore 1123860
ma_cross
ma20 406.7735
ma50 397.2122
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 406.04
prevMa50 397.401
spreadPct 2.41
isVolumeBreakout true
bollinger
lower 389.3582
upper 424.1888
position 上半部
rsi_short
value 38.54
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 1.85

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.6417811743087682,
        "turnoverUsdM": 852.55894549605,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.6,
    "stopLevels": {
      "symbol": "US.ELV",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 389.2372,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 2,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.6,
      "stop_loss_percent": 5.3,
      "take_profit_price": 445.1839,
      "target_multiplier": 2.2,
      "technical_strength": 2.15,
      "take_profit_percent": 8.3
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.5709098241590214,
    "stopLossPercent": 5.2835623486175365,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 65.6,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 58.6,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 406.7735,
    "ma50": 397.2122,
    "close": 410.95,
    "prevClose": 414.26,
    "avgVolume20": 1123860,
    "volumeRatio": 1.85,
    "changePercent": -0.8
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": -0.018556529423003454,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 1.9557446206782776,
      "ret_points": 0,
      "vol_points": 6,
      "range_ratio": 0.8902534035688924,
      "volat_points": 0,
      "day_range_pct": 0.020197079445258996,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 65.6,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.8,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 76,
        "contribution": 3.8
      },
      {
        "raw": 9.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 46,
        "contribution": 9.2
      },
      {
        "raw": 11.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 74.67,
        "contribution": 11.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 70,
        "contribution": 7
      },
      {
        "raw": 19.4,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 64.67,
        "contribution": 19.4
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 58.6,
    "details": [
      "基本面分析總分: 3.8/5分",
      "資金流分析總分: 9.2/20分",
      "市場環境分析總分: 11.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7/10分",
      "技術信號分析總分: 19.4/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.8,
      "資金流": 9.2,
      "市場環境": 11.2,
      "情緒分析": 6,
      "技術信號": 19.4,
      "風險管理": 7
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.5,
          "epsPoints": 0,
          "roePoints": 0.4,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 852.55894549605,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 1.6,
          "obvPoints": 0.8,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.ELV",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "良好",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.44
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 713.2354945,
                "ma50": 709.9511974999997,
                "name": "QQQ",
                "close": 721.45001,
                "points": 2
              },
              "spy": {
                "ma20": 764.3034934499999,
                "ma50": 759.73099818,
                "name": "SPY",
                "close": 761.69,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.6417811743087682,
          "atrPoints": 3,
          "cciPoints": 2.4,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 4,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142195356,
                "url": "https://finnhub.io/api/news?id=5026d066d14e93fd285f14b67eee910d578590ab1da321b577e3d0ffffe17858",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1789566004,
                "headline": "Are Medical Stocks Lagging  Elevance Health, Inc. (ELV) This Year?"
              },
              {
                "id": 142165895,
                "url": "https://finnhub.io/api/news?id=4e306319d28b9c86fab6c2c9dd4c4556d7f2825f07cdf375061043fa75828a64",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "ELV vs. DHR: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1789486803,
                "headline": "ELV or DHR: Which Is the Better Value Stock Right Now?"
              },
              {
                "id": 141950829,
                "url": "https://finnhub.io/api/news?id=0d6a03820241bbbe5b1f009058d13066016bbfb4577f67b0d52a1150f1e424ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "What a time it’s been for Elevance Health. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $414.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1788876918,
                "headline": "2 Reasons to Watch ELV and 1 to Stay Cautious"
              },
              {
                "id": 141446869,
                "url": "https://finnhub.io/api/news?id=f83be2ff10be414db328b84762aa96c3abb7549d3caafc3d998c02964c8ed095",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "After a strong 37.5% return over the past year, Elevance Health now trades with a high value score and an undervalued read on market multiples, which raises the question of whether the recent share price strength has fully reflected that signal or not. Elevance Health has delivered a 37.5% 1 year return, so any further upside now depends on how much fundamental value is still not priced in. The appointment of Dr. Patrick Fox to lead Carelon Behavioral Services, alongside greater use of AI in...",
                "category": "company",
                "datetime": 1788541717,
                "headline": "Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run"
              },
              {
                "id": 141362847,
                "url": "https://finnhub.io/api/news?id=46baef09383f41e21789fc2b3f9168ff7c68bd6636fa6ff9171ecead1c90b74f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "First Eagle Investment Management, an investment management company, released its Q2 2026 investor update for “First Eagle Global Fund”. The letter can be downloaded here. Easing tensions in the Middle East led to a strong rally in risk markets in Q2. The S&P 500 Index rose 15.2%, while the MSCI EAFE Index gained 10.8%. Growth […]",
                "category": "company",
                "datetime": 1788275973,
                "headline": "Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability"
              },
              {
                "id": 141362854,
                "url": "https://finnhub.io/api/news?id=04bd634a8b988a7cf311da2f49c8a860042d2747c93fb4b91b297dd3b8756cb9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Hotchkis & Wiley, an investment management company, released its second-quarter 2026 investor letter for the “Large Cap Fundamental Value Fund.” A copy can be downloaded here. Equity markets posted strong returns, with the Russell 1000 Value Index rising by 13.9%, although many individual stocks lagged. Notably, semiconductor stocks and AI-related sectors saw exceptional gains. The rally […]",
                "category": "company",
                "datetime": 1788275589,
                "headline": "Elevance Health (ELV): Bridging the Gap between Care and Coverage"
              },
              {
                "id": 141348697,
                "url": "https://finnhub.io/api/news?id=c3f11e3694dec0eb71a42656056e64871a363c44dc7c14ca74f28033388e390f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with Elevance Health (NYSE:ELV).",
                "category": "company",
                "datetime": 1787941732,
                "headline": "Health Insurance Providers Stocks Q2 In Review: Elevance Health (NYSE:ELV) Vs Peers"
              },
              {
                "id": 141348701,
                "url": "https://finnhub.io/api/news?id=ba59e6db11547a74cca1b53900d2a5fa3b6d53f4b318ab658e604a859899faf5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "In recent weeks, Elevance Health has been highlighted for strong Q2 2026 results, raised full-year guidance, and operational gains driven by AI-enabled efficiency and cost savings. At the same time, the appointment of Dr. Patrick Fox to lead Carelon Behavioral Services underscores Elevance Health’s emphasis on behavioral health capabilities within its broader health services platform. Next, we’ll examine how Elevance’s AI-driven margin improvements and refreshed behavioral health leadership...",
                "category": "company",
                "datetime": 1787757179,
                "headline": "Did AI-Driven Margins and New Behavioral Health Leadership Just Shift Elevance Health's (ELV) Investment Narrative?"
              }
            ],
            "raw_source": [
              {
                "id": 142261918,
                "url": "https://finnhub.io/api/news?id=46fedd06c559ba8b3d63e97060c25dad3687b4ac45e0e46d0a2425c82202bb5e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Track weekly dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend dates and pay dates here.",
                "category": "company",
                "datetime": 1789755255,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week September 20"
              },
              {
                "id": 142253967,
                "url": "https://finnhub.io/api/news?id=cc96e85bcbd3f911ee04bc5faedce46fa69ce08f2304cc6523cc0ba700260543",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CVS Health (CVS) keeps a little over a penny of profit from every dollar it takes in. A net margin of 1.2% reads like a verdict on the business. On $415.1 billion of revenue, one point of net margin is worth over $4 billion, and 1.2% is closer to a floor than a peak. Management has been working on it through 2026.",
                "category": "company",
                "datetime": 1789733701,
                "headline": "Should You Buy CVS Stock For The Margin Aetna Is Rebuilding?"
              },
              {
                "id": 142243261,
                "url": "https://finnhub.io/api/news?id=97da61e50488ab738935ec0c987e2d2f0bf7f71c8c70942a1e69ff508905292d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.",
                "category": "company",
                "datetime": 1789715600,
                "headline": "2 Surging  Stocks on Our Watchlist and 1 We Brush Off"
              },
              {
                "id": 142198233,
                "url": "https://finnhub.io/api/news?id=62893c934108390cb4e84f708579862ec5e7b3b4291db08db0f2465e4946203f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.",
                "category": "company",
                "datetime": 1789579013,
                "headline": "The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet"
              },
              {
                "id": 142195356,
                "url": "https://finnhub.io/api/news?id=5026d066d14e93fd285f14b67eee910d578590ab1da321b577e3d0ffffe17858",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1789566004,
                "headline": "Are Medical Stocks Lagging  Elevance Health, Inc. (ELV) This Year?"
              },
              {
                "id": 142194544,
                "url": "https://finnhub.io/api/news?id=fce05d1042311f51521afde0637491e147e66c86aae7741630cbd8ba237fa8a2",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2260474979/image_2260474979.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "During the quarter, we added 8 new positions and exited 6 positions, bringing the number of positions in the Fund to 43.",
                "category": "company",
                "datetime": 1789548840,
                "headline": "Baron Health Care Fund Q2 2026 Portfolio Activity"
              },
              {
                "id": 142165895,
                "url": "https://finnhub.io/api/news?id=4e306319d28b9c86fab6c2c9dd4c4556d7f2825f07cdf375061043fa75828a64",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "ELV vs. DHR: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1789486803,
                "headline": "ELV or DHR: Which Is the Better Value Stock Right Now?"
              },
              {
                "id": 142165607,
                "url": "https://finnhub.io/api/news?id=81c3d116e6c3b7c554af98f977c4bc6cd338554110e0abca84fed3a196ba0a12",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CVS Health's Health Services arm is gaining from pharmacy strength and improving care delivery, with robust new sales and clinic economics supporting growth.",
                "category": "company",
                "datetime": 1789481700,
                "headline": "Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth"
              },
              {
                "id": 142141425,
                "url": "https://finnhub.io/api/news?id=1319d644a68d1a16e7a0fdb153103e0f98cb9c4ea9eee6a94f946c434dcaf49d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The health care giant showered its owners with cash, yet the stock spent years in the slow lane. Here’s the accounting of what that trade-off actually delivered.",
                "category": "company",
                "datetime": 1789420257,
                "headline": "CVS Stock Returned $24B In Cash: Why Did It Still Lag The Market?"
              },
              {
                "id": 142141467,
                "url": "https://finnhub.io/api/news?id=40c7ec190f17456e6d4cedac5eaa7a53021f0b8cfbc64b185ac0b994c06ac9e3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth (UNH) has spent the past year repairing margins rather than chasing growth. The shares rebounded well ahead of any actual margin recovery: up about 38% over the past six months, though down about 6% over the past three, and still behind the S&P 500 over the past twelve months, 12.2% for the stock against 18.6% for the index. What argues for owning them now shows up in cash running ahead of reported profit.",
                "category": "company",
                "datetime": 1789414884,
                "headline": "Should You Buy UNH Stock Because Its Cash Runs Ahead Of Its Profit?"
              },
              {
                "id": 142095118,
                "url": "https://finnhub.io/api/news?id=741d6ea90e0aa04dbe0d39d21eb4f839bf1c5579d7b3969b84086379cdb5c707",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.",
                "category": "company",
                "datetime": 1789177145,
                "headline": "3 Profitable Stocks to Keep an Eye On"
              },
              {
                "id": 142088283,
                "url": "https://finnhub.io/api/news?id=8005a02c755811a9a0a209f2f5677afb24b48c9bf148a5123db5ea187fd45728",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CNC is set to reshape its Medicare Advantage business around dual-eligible members and a simpler footprint to drive margin recovery.",
                "category": "company",
                "datetime": 1789143420,
                "headline": "Can Centene's Medicare Advantage Strategy Unlock Better Margins?"
              },
              {
                "id": 142141590,
                "url": "https://finnhub.io/api/news?id=6f50b5fe50de9fb6fcc234af99e7fa929b8bff2e5a1b149a55e571d323dcebee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Key Takeaways:Guidance Raised: Elevance Health lifted 2026 adjusted EPS guidance to at least $27, up from prior levels, after a strong Q2. Price Projection: Based on current execution, ELV stock could reach $494 by December 2028.",
                "category": "company",
                "datetime": 1789133912,
                "headline": "Up 36% in the Last 12 Months, Does Elevance Health Stock Have More Room to Run Through 2028?"
              },
              {
                "id": 142064801,
                "url": "https://finnhub.io/api/news?id=986a6117d59e8175d3255bd7bd52028ee01dd339371ca80d62205c5bea18363a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.",
                "category": "company",
                "datetime": 1789069012,
                "headline": "Should You Buy Elevance Health Stock For The Margin It Lost?"
              },
              {
                "id": 142064393,
                "url": "https://finnhub.io/api/news?id=7c28e78d9040a5cce97fe2b77384836940d53d535f5f71724541cccc657ad8ee",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "ELV",
                "summary": "Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1789067101,
                "headline": "Thursday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 142063328,
                "url": "https://finnhub.io/api/news?id=0ddaecaced7b45415c54683e8f459cfc0dd0f482dcb3ec10e83497f59326cbf3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.",
                "category": "company",
                "datetime": 1789061100,
                "headline": "UnitedHealth Reshapes Florida WellMed Operations With TPG Deal"
              },
              {
                "id": 142062620,
                "url": "https://finnhub.io/api/news?id=42d1713943407a8373594164c6027ae51524d6e82d99ced0e1abd43763cbc25b",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "ELV",
                "summary": "Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.",
                "category": "company",
                "datetime": 1789058101,
                "headline": "What's going on in today's session: S&P500 movers"
              },
              {
                "id": 142064037,
                "url": "https://finnhub.io/api/news?id=57d493ab3351dc74de676b0cd87b6e9bd1621b6634e7636031016eeb9aed01a9",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/10/Market--Down--Creative-Crash-Recession-C.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Crude jumped 6% and 30-year Treasury yields hit levels last seen in 2007 as a hot PPI print pushed Fed rate-hike odds toward 70% ahead of Friday's CPI.",
                "category": "company",
                "datetime": 1789050419,
                "headline": "Stock Market Today: Nasdaq 100 Tumbles as Oil Spikes 6%, Yields Hit 19-Year High"
              },
              {
                "id": 142066812,
                "url": "https://finnhub.io/api/news?id=c3a8490e26f351d1f1e73fe0cfa27c4a9c9d2378d030b2065497eda26ab93539",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/10/Elevance-Health-Photo-by-Jonathan-Weiss-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance Health shares are jumping Thursday after the company reaffirmed its FY26 earnings guidance ahead of a series of investor meetings.",
                "category": "company",
                "datetime": 1789049583,
                "headline": "Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation"
              },
              {
                "id": 142060147,
                "url": "https://finnhub.io/api/news?id=10663dfaeed0ebff97aaefb390f63748c5ff769ad0026a71593c7860874b7688",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health Inc (NYSE:ELV) recently announced a total dividend of $1.72 per share, with the ex-dividend date set for 2026-09-10.  For investors, the ex-dividend date is a critical marker: shareholders must own the stock before this date to qualify for the upcoming payment.  As investors look forward to this next distribution, the spotlight also shines on the company's dividend history, yield, and growth rates.",
                "category": "company",
                "datetime": 1789038250,
                "headline": "Elevance Health Inc's Dividend Analysis"
              },
              {
                "id": 142066813,
                "url": "https://finnhub.io/api/news?id=75266bf8779312c3481306c942803f68b1d5d054daa55df5708350b7f3aa6de4",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $20.10 vs $20.26 Est..",
                "category": "company",
                "datetime": 1789021705,
                "headline": "Elevance Health Affirms FY2026  GAAP EPS expected to be more than $20.10 vs $20.26 Est"
              },
              {
                "id": 142066814,
                "url": "https://finnhub.io/api/news?id=c83bfcfa124b06b727e41e969f3edbdbe6c30d149d6bbfaf7d6627840dccba4e",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $27.00 vs $26.91 Est..",
                "category": "company",
                "datetime": 1789021680,
                "headline": "Elevance Health Affirms FY2026  Adj EPS expected to be more than $27.00 vs $26.91 Est"
              },
              {
                "id": 142028659,
                "url": "https://finnhub.io/api/news?id=0081c272b61c689e1879a429e5f7c5cd199146ca47c277f5122abab9309cdee1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.",
                "category": "company",
                "datetime": 1788982210,
                "headline": "Why Is UNH Stock Trading At A Premium With The Slowest Growth?"
              },
              {
                "id": 142025949,
                "url": "https://finnhub.io/api/news?id=1e60277542dd68ec98f2ca5040753093f4e61bd880edcdf64de9408c92768f2e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.",
                "category": "company",
                "datetime": 1788964814,
                "headline": "UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation"
              },
              {
                "id": 141950829,
                "url": "https://finnhub.io/api/news?id=0d6a03820241bbbe5b1f009058d13066016bbfb4577f67b0d52a1150f1e424ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "What a time it’s been for Elevance Health. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $414.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1788876918,
                "headline": "2 Reasons to Watch ELV and 1 to Stay Cautious"
              },
              {
                "id": 141546908,
                "url": "https://finnhub.io/api/news?id=8e571c6258a78e295e3d3b62ceae232f24f7212af2894b0de642b2676a6a05ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.",
                "category": "company",
                "datetime": 1788642735,
                "headline": "Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2."
              },
              {
                "id": 141485601,
                "url": "https://finnhub.io/api/news?id=a14fa2d71c991d1424c650e89ccc0365f647e29aec84a754bdf9a4133b2e0743",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Explore this week’s dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend and pay dates.",
                "category": "company",
                "datetime": 1788562641,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week September 6"
              },
              {
                "id": 141446869,
                "url": "https://finnhub.io/api/news?id=f83be2ff10be414db328b84762aa96c3abb7549d3caafc3d998c02964c8ed095",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "After a strong 37.5% return over the past year, Elevance Health now trades with a high value score and an undervalued read on market multiples, which raises the question of whether the recent share price strength has fully reflected that signal or not. Elevance Health has delivered a 37.5% 1 year return, so any further upside now depends on how much fundamental value is still not priced in. The appointment of Dr. Patrick Fox to lead Carelon Behavioral Services, alongside greater use of AI in...",
                "category": "company",
                "datetime": 1788541717,
                "headline": "Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run"
              },
              {
                "id": 141446662,
                "url": "https://finnhub.io/api/news?id=5d83f5780b6dfb902bdb5621ef012795ad52a453dd0b77ba71da028ec44295d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.",
                "category": "company",
                "datetime": 1788537840,
                "headline": "UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?"
              },
              {
                "id": 141406653,
                "url": "https://finnhub.io/api/news?id=0fc4ece3606f4bc356908fcf90fe606852128b69087dfef8e68812e6877e4525",
                "image": "",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "",
                "category": "company",
                "datetime": 1788468965,
                "headline": "Tracking Leon Cooperman's Omega Advisors Portfolio - Q2 2026 Update"
              },
              {
                "id": 141402794,
                "url": "https://finnhub.io/api/news?id=c5b2226aff37f7fdea42ffc0a3e08c7d47d198279f6393e69e1234a596a2456a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.",
                "category": "company",
                "datetime": 1788456945,
                "headline": "UnitedHealth Stock Recovered Before Its Margins Did"
              },
              {
                "id": 141400357,
                "url": "https://finnhub.io/api/news?id=19b31dad684a09c10510e4d143d2601be86618c98904802e5c585553b6fe199e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The market has crowned this healthcare giant the winner of its group, but a look at the underlying business raises the question of whether the celebration started too soon.",
                "category": "company",
                "datetime": 1788446735,
                "headline": "CVS Stock Has Left Its Peers Behind. Or Has It?"
              },
              {
                "id": 141376481,
                "url": "https://finnhub.io/api/news?id=c5142c9c5bbbb3009728f0775ed74e8ff2bb7da9ccaf6344e74f6c3910f5200e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CNC's 117% rally now has support from improving margins, firmer pricing and higher earnings expectations, while valuation remains below key peers.",
                "category": "company",
                "datetime": 1788360360,
                "headline": "Centene Stock Roars Back 117% in a Year: Is CNC Still a Buy?"
              },
              {
                "id": 141379955,
                "url": "https://finnhub.io/api/news?id=9ee49755478826af4de84decd2b0c6ea28d749fc2ddb35d8a026a818d34b6a7c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health has underperformed its industry peers over the past year, but analysts are moderately optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1788353840,
                "headline": "How Is Elevance Health’s Stock Performance Compared to Other Health Providers?"
              },
              {
                "id": 141369881,
                "url": "https://finnhub.io/api/news?id=e4986c7e355043e59c656a1c52dbe0d2e2b30ebbe6e03009de611177fa730fe7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CNC's Marketplace recovery is boosting profitability as better pricing, medical cost trends and risk dynamics reshape its earnings outlook.",
                "category": "company",
                "datetime": 1788281640,
                "headline": "Can Centene's Marketplace Recovery Fuel Stronger Earnings Growth?"
              },
              {
                "id": 141368964,
                "url": "https://finnhub.io/api/news?id=e5186e485dc68957760302a6c425447b90b006aca680e1528a0a389ed7c70459",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "ELV",
                "summary": "Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.",
                "category": "company",
                "datetime": 1788280501,
                "headline": "Which S&P500 stocks are moving on Tuesday?"
              },
              {
                "id": 141362847,
                "url": "https://finnhub.io/api/news?id=46baef09383f41e21789fc2b3f9168ff7c68bd6636fa6ff9171ecead1c90b74f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "First Eagle Investment Management, an investment management company, released its Q2 2026 investor update for “First Eagle Global Fund”. The letter can be downloaded here. Easing tensions in the Middle East led to a strong rally in risk markets in Q2. The S&P 500 Index rose 15.2%, while the MSCI EAFE Index gained 10.8%. Growth […]",
                "category": "company",
                "datetime": 1788275973,
                "headline": "Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability"
              },
              {
                "id": 141362854,
                "url": "https://finnhub.io/api/news?id=04bd634a8b988a7cf311da2f49c8a860042d2747c93fb4b91b297dd3b8756cb9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Hotchkis & Wiley, an investment management company, released its second-quarter 2026 investor letter for the “Large Cap Fundamental Value Fund.” A copy can be downloaded here. Equity markets posted strong returns, with the Russell 1000 Value Index rising by 13.9%, although many individual stocks lagged. Notably, semiconductor stocks and AI-related sectors saw exceptional gains. The rally […]",
                "category": "company",
                "datetime": 1788275589,
                "headline": "Elevance Health (ELV): Bridging the Gap between Care and Coverage"
              },
              {
                "id": 141370499,
                "url": "https://finnhub.io/api/news?id=449bfd73faa2a0619ff0244e90ac9f9188892e5b55be042037046fe31ded0beb",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss",
                "category": "company",
                "datetime": 1788271464,
                "headline": "FDA Says It Has Received 990 Adverse Event Reports Tied To Compounded Semaglutide And More Than 730 Tied To Compounded Tirzepatide; Establishes Import Alert For Compounded GLP-1 Active Pharmaceutical Ingredients"
              },
              {
                "id": 141369187,
                "url": "https://finnhub.io/api/news?id=efc3da274f0ad5bd69acce8293e14118c2980c701e25a977ad4af86808ec1c51",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/01/New-York-Ny-Usa-march-21--2024-The-New-Y.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.",
                "category": "company",
                "datetime": 1788267096,
                "headline": "Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today"
              },
              {
                "id": 141033408,
                "url": "https://finnhub.io/api/news?id=8ac2e8d39f09e3624d224617145a6038b10b9d9614d10aeb8b095fe16b9b65b8",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "",
                "category": "company",
                "datetime": 1788263573,
                "headline": "Freenome shares are trading higher after the company announced FDA approval for its SimpleSreen CRC blood-based screening test."
              },
              {
                "id": 141361168,
                "url": "https://finnhub.io/api/news?id=1cbf7f516ca93aacdc4e94985c792cd793c6948f29279ace82eac658358e283e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Consensus knocks a quarter off the health insurer's earnings multiple over two years, part of it measurement, and almost none of it from selling more coverage.",
                "category": "company",
                "datetime": 1788204328,
                "headline": "UNH Stock Gets Cheaper Only If The Margins Come Back"
              },
              {
                "id": 141348696,
                "url": "https://finnhub.io/api/news?id=e21e41f3ee9a082fe4b89d56b633a2d96bf0fff4264582b1399beef45b1bd20e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Its market-shock drawdowns have been ordinary in depth, and some of its longest waits back to the old high came after falls the index barely noticed.",
                "category": "company",
                "datetime": 1787943961,
                "headline": "Is CVS Stock Set for a Rebound?"
              },
              {
                "id": 141348697,
                "url": "https://finnhub.io/api/news?id=c3f11e3694dec0eb71a42656056e64871a363c44dc7c14ca74f28033388e390f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with Elevance Health (NYSE:ELV).",
                "category": "company",
                "datetime": 1787941732,
                "headline": "Health Insurance Providers Stocks Q2 In Review: Elevance Health (NYSE:ELV) Vs Peers"
              },
              {
                "id": 141348698,
                "url": "https://finnhub.io/api/news?id=9cb7ab406e99ebb67666f4debc44ace31c983016f37660383b80409497e50f1b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1787934624,
                "headline": "Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 141348699,
                "url": "https://finnhub.io/api/news?id=7b9aaf0f06e7f13118a9e7ec9ec53b07edb5eb36492e127cd742bf487132234d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The healthcare giant sent a fortune back to its owners, but the market yawned. Here’s the real accounting of what that cash bought, and what it didn't.",
                "category": "company",
                "datetime": 1787876791,
                "headline": "Can a $68 Billion Payout Save UNH Stock?"
              },
              {
                "id": 141348700,
                "url": "https://finnhub.io/api/news?id=ab70e49cb3984bc11c8bfbdab7821b88357b14a0daba3b15666b8acbeca953a3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CI's Smart Coverage links medical and supplemental benefits, offering up to $7,000 and automated claims for costly health events.",
                "category": "company",
                "datetime": 1787844000,
                "headline": "Can Cigna's Smart Coverage Help Close Health-Cost Gaps?"
              },
              {
                "id": 141326656,
                "url": "https://finnhub.io/api/news?id=f0ee289a15577c07a4f88b461b3b9df0cab874642345723232053d6898832f08",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1972341389/image_1972341389.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Ruane, Cunniff & Goldfarb Q2 2026 13F: key holdings, new buys & trims, and Sequoia Fund vs S&P 500. Read here for a detailed investment analysis.",
                "category": "company",
                "datetime": 1787781184,
                "headline": "Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2026 Update"
              },
              {
                "id": 141348701,
                "url": "https://finnhub.io/api/news?id=ba59e6db11547a74cca1b53900d2a5fa3b6d53f4b318ab658e604a859899faf5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "In recent weeks, Elevance Health has been highlighted for strong Q2 2026 results, raised full-year guidance, and operational gains driven by AI-enabled efficiency and cost savings. At the same time, the appointment of Dr. Patrick Fox to lead Carelon Behavioral Services underscores Elevance Health’s emphasis on behavioral health capabilities within its broader health services platform. Next, we’ll examine how Elevance’s AI-driven margin improvements and refreshed behavioral health leadership...",
                "category": "company",
                "datetime": 1787757179,
                "headline": "Did AI-Driven Margins and New Behavioral Health Leadership Just Shift Elevance Health's (ELV) Investment Narrative?"
              },
              {
                "id": 141348702,
                "url": "https://finnhub.io/api/news?id=2a90f9ffa47c2a658bb35ed845fdefe5b254645d20974fbff3f7fa488adff391",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (ELV) drew fresh attention this week after its Carelon Behavioral Health unit appointed forensic psychiatrist Dr. Patrick Fox as leader, putting behavioral services for more than 61 million members under new oversight. Those leadership changes come as Elevance Health trades at US$398.87, with a 30 day share price return of 5.61% and year to date share price return of 12.60%. The 1 year total shareholder return of 31.36% contrasts with a 3 year total shareholder return that is...",
                "category": "company",
                "datetime": 1787745974,
                "headline": "Elevance Health (ELV) Could Be 11% Undervalued As Carelon Names New Behavioral Health Leader"
              },
              {
                "id": 141348703,
                "url": "https://finnhub.io/api/news?id=249326dbb0ac108ed2dcd6a2970fc004980a25cf7513cfae72f642c8527d55f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Sound Shore Management, an investment management firm, has released its investor letter for the second quarter of 2026. The letter can be downloaded here. The Sound Shore Fund’s Investor Class (SSHFX) and Institutional Class (SSHVX) rose 10.48% and 10.58% in the second quarter of 2026, trailing the Russell 1000 Value Index’s 13.87% and the S&P […]",
                "category": "company",
                "datetime": 1787685630,
                "headline": "Is Elevance Health (ELV) a Mispriced Opportunity?"
              },
              {
                "id": 141348704,
                "url": "https://finnhub.io/api/news?id=f579d4e655a1c6b3865758f2eb885d4aaf89fa1832205ed74d9d2c3be5f56e5d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.",
                "category": "company",
                "datetime": 1787677080,
                "headline": "UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?"
              },
              {
                "id": 141348705,
                "url": "https://finnhub.io/api/news?id=a697839727b60d968b56f21ed5428c6d3e917c24657401be3326394a8688a31f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Dr. Patrick Fox, a forensic psychiatrist and health plan leader, will take the reins at Carelon Behavioral Services effective immediately. His experience will be “invaluable” for the unit, a top Elevance executive said.",
                "category": "company",
                "datetime": 1787653665,
                "headline": "Elevance’s behavioral health division nabs new president"
              },
              {
                "id": 141348706,
                "url": "https://finnhub.io/api/news?id=151b0d4bdd9467e584b2144af927c6645c3f8a4360ead424569dce82f9058d54",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Medicare's improvement is real but not a turn in cost trend, while commercial costs keep running higher and the margin fix there has slipped again.",
                "category": "company",
                "datetime": 1787594668,
                "headline": "UnitedHealth Stock's Biggest Risk Sits In The Commercial Book"
              },
              {
                "id": 141348707,
                "url": "https://finnhub.io/api/news?id=7f5f74d99e12d15db763c6c22ab7d23ac40d8468ba28801a0634d10239c11e38",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Despite Elevance Health's outperformance relative to the broader market over the past 52 weeks, Wall Street analysts remain cautiously optimistic about the stock's prospects.",
                "category": "company",
                "datetime": 1787588640,
                "headline": "Elevance Health Stock Outlook: Is Wall Street Bullish or Bearish?"
              },
              {
                "id": 141278437,
                "url": "https://finnhub.io/api/news?id=b295eac02aec9c6a14a41b24daf8c516e0e5d52cc2f5cdffb36783e0ac4015ed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The healthcare giant is wrestling with costs in one part of its business, and the stock's recent dip has investors wondering if this is the moment to step in.",
                "category": "company",
                "datetime": 1787349486,
                "headline": "Is The Pullback In UNH Stock A Glitch Or A Warning?"
              },
              {
                "id": 141278439,
                "url": "https://finnhub.io/api/news?id=0aa4c6eab65e8fa1fe312f6d5ad967c837c98714d3987241138d505991dec443",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UNH is prioritizing Medicare Advantage profitability over membership growth, using tighter benefits, pricing and cost controls to improve margins.",
                "category": "company",
                "datetime": 1787333520,
                "headline": "Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?"
              },
              {
                "id": 141280264,
                "url": "https://finnhub.io/api/news?id=b6a7575647dc6c1fed55742c2871f075dcf6c8397314691554b3e8c20f9bd644",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Medpace (MEDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1787329807,
                "headline": "Why Is Medpace (MEDP) Up 1.1% Since Last Earnings Report?"
              },
              {
                "id": 141280265,
                "url": "https://finnhub.io/api/news?id=351df5c90b8bb6fd905405664cbbd083be75975fdd08673ee992605c35a59174",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.",
                "category": "company",
                "datetime": 1787327027,
                "headline": "2 Large-Cap Stocks with Promising Prospects and 1 Facing Headwinds"
              },
              {
                "id": 141278449,
                "url": "https://finnhub.io/api/news?id=984f68cae88b01dc0468fddba0bc7fb289ae283fd6a8aabceb2bf6c887b1fa62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "HUM's Star Ratings recovery is set to show early progress, but October's CMS release will test its MA turnaround and path to a 2028 margin target.",
                "category": "company",
                "datetime": 1787244420,
                "headline": "Can Humana's Star Ratings Rebound Unlock MA Earnings Power?"
              },
              {
                "id": 141258963,
                "url": "https://finnhub.io/api/news?id=a415fc07907197a7f9360b6450ff2edea764c2626a17877f0e266de5b3e9d0aa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UNH's improving medical costs, higher EPS estimates and capital returns support its recovery, but regulatory risks remain.",
                "category": "company",
                "datetime": 1787159760,
                "headline": "UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 4,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 61,
            "discarded_article_count": 51
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 19.4,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50;升放量(近10日4日);Ready=N;Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 999150,
              "down_days": 5,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1290450,
              "avg_vol_20": 1060775,
              "avg_vol_30": 999150,
              "range_pct_10": 0.08704226579773044,
              "range_pct_20": 0.08850229739622104,
              "range_pct_30": 0.1005718676098828,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 4,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.291547815643297,
              "dist_to_20d_high": 0.037970830396075725,
              "down_shrink_days": 0,
              "breakout_level_20d": 427.17001,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.8654732965223084
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.6417811743087682,
              "turnoverUsdM": 852.55894549605,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.6,
          "stopLevels": {
            "symbol": "US.ELV",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 389.2372,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 2,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.6,
            "stop_loss_percent": 5.3,
            "take_profit_price": 445.1839,
            "target_multiplier": 2.2,
            "technical_strength": 2.15,
            "take_profit_percent": 8.3
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.5709098241590214,
          "stopLossPercent": 5.2835623486175365,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 10.8564,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.64
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "平衡",
      "score": 6,
      "value": 31.22
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1267
    },
    "kdj": {
      "d": 66.19,
      "j": 56.81,
      "k": 63.06,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 42.63
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": 5941395,
      "recentSlope": -148020.5,
      "previousSlope": 51050
    },
    "rsi": 59.6,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 404.7761,
      "position": "SAR喺價下",
      "distancePct": 1.5,
      "previousTrend": "上升"
    },
    "ma50": 397.2122,
    "macd": {
      "macd": 5.2993829863283395,
      "trend": "強烈看漲",
      "signal": 4.964240333402188,
      "histogram": 0.33514265292615164
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 408.6706,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 7
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.85,
      "score": 6,
      "avgVolume": 1123860,
      "currentVolume": 2074605
    },
    "derived": {
      "ma20": 406.7735,
      "ma50": 397.2122,
      "prevClose": 414.26,
      "avgVolume10": 1375331,
      "avgVolume20": 1123860,
      "changePercent": -0.8,
      "avgVolumeForScore": 1123860
    },
    "ma_cross": {
      "ma20": 406.7735,
      "ma50": 397.2122,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 406.04,
      "prevMa50": 397.401,
      "spreadPct": 2.41,
      "isVolumeBreakout": true
    },
    "bollinger": {
      "lower": 389.3582,
      "upper": 424.1888,
      "position": "上半部"
    },
    "rsi_short": 38.54,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.85
    }
  }
}

Raw metrics JSON

{
  "close": 410.95,
  "volume": 2074605,
  "changePercent": -0.8
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.